Neovacs published the initial results of a phase I/II study with IFN?-Kinoid in lupus patients that highlights the safety, immunogenicity, and the pharmacodynamics of the therapy, according to a report by Neovacs.
Teva Pharmaceutical reported preliminary data from two studies, Coptimize and QualiCop.
The Epstein-Barr virus, belonging to the herpesviruses family, which also includes the herpes simplex virus and the cytomegalovirus, is one of the environmental factors that might cause multiple sclerosis.
Researchers have identified a novel gene in the nucleus of muscle and brain cells that affects heart development and the aging process. Their investigation brings the promise of new treatments for an old, failing heart.
Avantor Performance Materials has completed the first supply chain security audit by Rx-360, a consortium of pharmaceutical and biotechnology companies and suppliers dedicated to improving pharmaceutical supply chain security.
Clinipace Worldwide, a global digital clinical research organization, and Swiss-based PFC Pharma Focus announced a merger agreement under which Clinipace Worldwide has acquired all outstanding shares of privately-held PFC and its subsidiaries.
METTLER TOLEDO has introduced LevelSens; the new titration, density, and refractive index accessory for solution monitoring to increase security in the laboratory.
Researchers now have a faster, surer way to organize and track their highly important cryopreserved samples in a biobank. WHEATON introduces the KeepIT Freezer Box for biobanking applications.
Glycotope GmbH has recently received approvals to initiate clinical trials for its first glycooptimized non-antibody protein therapeutic FSH-GEX, for in vitro fertilisation and infertility.
Lantheus Medical Imaging, Inc. announced data from a Phase 2 clinical trial that demonstrated positron emission tomography myocardial perfusion imaging with flurpiridaz F 18 was superior for detecting coronary artery disease.
Perrigo Company announced that it has received tentative approval from the U.S. Food and Drug Administration for its abbreviated new drug application for Levocetirizine Solution, 2.5 mg/5 mL, a generic version of UCB’s Xyzal Oral Solution.
Abbott announced that it has received approval from the U.S. Food and Drug Administration to market its RealTime PCR test for measuring the viral load of hepatitis C, the leading cause of liver cancer in the United States.
Men who regularly drink coffee appear to have a lower risk of developing a lethal form of prostate cancer. What's more, the lower risk was evident among men who drank either regular or decaffeinated coffee.
Researchers have identified a new avenue for treating breast cancer. In 20 to 30% of breast cancer patients, the over-expression of a particular protein (human epidermal growth factor-2) is the main cause of the proliferation of cancer cells.
Canadian drugmaker Aeterna Zentaris Inc. reported a larger first-quarter loss, as higher expenses canceled out greater sales of its hormone drug Cetrotide. The company said it lost $10.1 million.